Maureen G Conlan

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Metastatic Breast Cancer

Estrogen Receptor

Positron Emission Tomography

Top Venues

Breast cancer research : BCR

Clinical cancer research : an official journal of the American Association for Cancer Research

European journal of drug metabolism and pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Glenn J Hanna, Myung-Ju Ahn, Jameel Muzaffar, Bhumsuk Keam, Daniel W Bowles, Deborah J Wong, Alan L Ho, Sung-Bae Kim, Francis P Worden, Tak Yun, Xianzhang Meng, Jan M Van Tornout, Maureen G Conlan, Hyunseok Kang
A Phase 2 Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Maureen G Conlan, Erik F J de Vries, Awjm Glaudemans, Yamei Wang, Steven Troy
Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women. European journal of drug metabolism and pharmacokinetics 45 (5) (2021)
Agnes Jager, Elisabeth G E de Vries, C Willemien Menke-van der Houven van Oordt, Patrick Neven, Clasina M Venema, Andor W J M Glaudemans, Yamei Wang, Rebecca G Bagley, Maureen G Conlan, Philippe Aftimos
A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imaging. Breast cancer research : BCR 22 (1) (2020)